Startup StaffHealth has secured $6.5 million (approximately 24 million PLN) in funding. Among the investors are Rubicon Partners, Maciej Zientara, and Wojciech Duda. They jointly believe the company has the potential to capture a significant share of the multi-billion-dollar but still fragmented temporary labor market in the U.S. healthcare sector.
StaffHealth addresses a real staffing challenge faced by hospitals and medical facilities across the United States. At the same time, it meets the needs of medical personnel seeking greater flexibility and control over their schedules.
“From our perspective, the most important aspect of StaffHealth is that it solves a significant problem regarding access to medical staff by professional healthcare facilities — specifically dynamic shift management. For employees, it’s an app that lets medical personnel browse or select available shifts and set their own schedules. For facilities, it enables quick staffing and filling of workforce gaps,” says Wojciech Duda, investor and Vice President of the Board at Duda Holding.
At the core of the company is a technologically advanced platform developed in Poland. Operational development for the U.S. market is handled by an experienced American team.
“We really liked that the technology is anchored in Poland, which is both efficient and cost-effective, while the product and market focus is on the huge American market. Thanks to the work of Mariusz Nowak (CTO), they created a highly scalable marketplace solution that can quickly handle a large number of leads using an established IT platform. This was the primary trigger for my confidence that in a well-established market like this, you can create real technological and cost advantages,” comments Maciej Zientara, investor and founder of Supernova Group.
The Rubicon Partners fund acts as a venture builder in this project — not only providing capital but actively participating in building the company.
“In this situation, Rubicon, along with myself leading the project, built the Polish side of the enterprise. On the other hand, we have our U.S.-based co-founders and partners who come from the temporary staffing sector in healthcare. So we combined the industry experience of people who were active in the field when it was still analog with technology from Poland. This mix seems very promising,” says Grzegorz Golec, co-CEO of StaffHealth and managing partner at Rubicon Partners.
The market StaffHealth operates in is valued at around $20 billion. The largest players hold only about a dozen percent market share, leaving room for new technologically advanced entrants.
“This market is still forming, consolidation processes will continue, and anyone active in it today has a very good chance of securing a leadership position in the coming years. This is an additional argument that makes this investment seem quite promising,” adds Grzegorz Golec.
According to Mariusz Nowak, StaffHealth’s CTO, there are about 5 million nurses working in the B2B model in the U.S. The startup’s biggest competitor has already raised $500 million in funding.
Currently, a SAFE round raising $2.5 million is underway to support further development, including potential acquisitions of traditional staffing agencies. These funds will convert into equity in the next round planned for late 2025 or early 2026.
Investors identify maintaining growth momentum and scaling operations among the challenges.
“I view risk somewhat differently — it’s about keeping pace in the market. Because the company is growing rapidly, working capital demand will intensify. The company will need further financing rounds to keep up with needs and competition. If the market wants this solution, we need to move fast. That’s why we have the current SAFE and this round. We need to add fuel now,” emphasizes Maciej Zientara.
Direct oversight of the company and day-to-day team collaboration is managed by Grzegorz Golec, providing investors comfort despite geographic dispersion.
Investors foresee StaffHealth’s valuation increasing five to seven times over the next few years, highlighting various possible exit scenarios.
“If the company consistently follows the growth path, it will be an attractive target for private equity funds. I also envision other scenarios, such as an IPO. This company could be a good dividend payer. Of course, there is also the possibility of an exit to a strategic industry investor once we are sufficiently large, as we expect appetite for consolidation deals from the biggest players given the market’s current development stage,” says Grzegorz Golec.
“I am convinced we will finish with a typical M&A deal. Americans love growth and building value through M&A. I expect that between the third and fourth year from now, the company’s value will increase five to seven times and we will simply be bought out,” concludes Maciej Zientara.
Source: https://ceo.com.pl/staffhealth-pozyskuje-24-mln-zl-inwestorem-min-maciej-zientara-47361
